Company Theseus Pharmaceuticals, Inc.
Equities
THRX
US88369M1018
Biotechnology & Medical Research
Business Summary
Number of employees: 38
Managers
Managers | Title | Age | Since |
---|---|---|---|
- | - | ||
59 | - | ||
66 | - | ||
Bradford Dahms
PSD | President | 36 | 21-04-30 |
Leonard Rozamus
CTO | Chief Tech/Sci/R&D Officer | - | - |
Katie Dahlstrom
CTO | Chief Tech/Sci/R&D Officer | - | - |
Investor Relations Contact | - | - | |
Corporate Officer/Principal | - | - | |
Benjamin Enerson
LAW | General Counsel | - | - |
Comptroller/Controller/Auditor | - | 21-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bradford Dahms
PSD | President | 36 | 21-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,649,172 | 44,649,172 ( 100.00 %) | 0 | 100.00 % |
Company contact information
![address Theseus Pharmaceuticals, Inc.(THRX)](https://cdn.zonebourse.com/static/address/127830003.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+19.65% | 124B | |
+19.92% | 114B | |
+21.11% | 25.83B | |
-23.65% | 19.42B | |
-18.17% | 16.2B | |
-20.16% | 15.31B | |
+54.80% | 14.32B | |
+8.21% | 14.31B | |
-48.79% | 14.19B |